Neurotrophic factor expression in vestibular schwannoma;Expression neurotropher faktoren im vestibularisschwannom - Eine übersicht

Laryngo- Rhino- Otologie

Volumn 85, Issue 10, 2006, Pages 731-737

  Diensthuber, M ^a   Lenarz, T ^a   Stöver, Timo ^a,b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Klinik und Poliklinik fur Hals Nasen Ohrenheilkunde   (Germany)

Author keywords

Growth; Growth factors; Neurotrophic factors; Vestibular schwannoma

Indexed keywords

EPIDERMAL GROWTH FACTOR; ERYTHROPOIETIN; FIBROBLAST GROWTH FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; NEU DIFFERENTIATION FACTOR; NEUROTROPHIC FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

CHROMOSOME 22Q; GENETIC ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; INTRACRANIAL TUMOR; NEURILEMOMA; NEUROFIBROMATOSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR SUPPRESSOR GENE;

ADULT; ANIMALS; CHROMOSOMES, HUMAN, PAIR 22; EPIDERMAL GROWTH FACTOR; FIBROBLAST GROWTH FACTORS; GENES, TUMOR SUPPRESSOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; INCIDENCE; MICE; MICE, HAIRLESS; MICE, INBRED HRS; NERVE GROWTH FACTORS; NEUROFIBROMATOSIS 2; NEUROMA, ACOUSTIC; SCHWANN CELLS; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTORS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 33750065399     PISSN: 09358943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-925286     Document Type: Review

References (78)

1. Irving RM, Moffat DA, Hardy DG, Barton DE, Xuereb JH, Maher ER. Somatic NF2 gene mutations in familial and non-familial vestibular schwannoma. Hum Mol Genet 1994; 3: 347-350
2. Moffat DA, Hardy DG, Irving RM, Viani L, Beynon GJ, Baguley DM. Referral patterns in vestibular schwannomas. Clin Otolaryngol 1995; 20: 80-83
3. Ebadi M, Bashir RM, Heidrick ML, Hamada FM, Refaey HE, Hamed A, Helal G, Baxi MD, Cerutis DR, Lassi NK. Neurotrophins and their receptors in nerve injury and repair. Neurochem Int 1997; 30: 347-374
4. Mattson MP, Cheng B, Smith-Swintosky VL. Mechanisms of neurotrophic factor protection against calcium- and free radical-mediated excitotoxic injury: implications for treating neurodegenerative disorders. Exp Neurol 1993; 124: 89-95
5. Roberts AB, Sporn MB. The transforming growth factors βs. In: Sporn MB, Roberts AB (eds). Handbook of experimental pharmacology, Vol 95. Heidelberg: Springer, 1991: 419-472
6. Pirvola U, Ylikoski J, Palgi J, Lehtonen E, Arumae U, Saarma M. Brain-derived neurotrophic factor and neurotrophin 3 mRNAs in the peripheral target fields of developing inner ear ganglia. Proc Natl Acad Sci USA 1992; 89: 9915-9919
7. Wiechers B, Gestwa G, Mack A, Carroll P, Zenner HP, Knipper M. A changing pattern of brain-derived neurotrophic factor expression correlates with the rearrangement of fibers during cochlear development of rats and mice. J Neurosci 1999; 19: 3033-3042
8. Ylikoski J, Pirvola U, Virkkala J, Suvanto P, Liang XQ, Magal E, Altschuler R, Miller JM, Saarma M. Guinea pig auditory neurons are protected by glial cell line-derived growth factor from degeneration after noise trauma. Hear Res 1998; 124: 17-26
9. Oestreicher E, Knipper M, Arnold A, Zenner HP, Felix D. Neurotrophin 3 potentiates glutamatergic responses of IHC afferents in the cochlea in vivo. Eur J Neurosci 2000; 12: 1584-1590
10. Yancopoulos GD, Maisonpierre PC, Ip NY, Aldrich TH, Belluscio L, Boulton TG, Cobb MH, Squinto SP, Furth ME. Neurotrophic factors, their receptors, and the signal transduction pathways they activate. Cold Spring Harb Symp Quant Biol 1990; 55: 371-379
11. Maran AG, Wilson JA, Gaze MN. The nature of the head and neck cancer. Eur Arch Otorhinolaryngol 1993; 250: 127-132
12. Levi-Montalcini R, Hamburger V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool 1951; 116: 321-361
13. Shu XQ, Mendell LM. Neurotrophins and hyperalgesia. Proc Natl Acad Sci USA 1999; 96: 7693-7696
14. Levi-Montalcini R, Skaper SD, Dal Toso R, Petrelli L, Leon A. Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci 1996; 19: 514-520
15. Mattson MP, Mark RJ. Excitotoxicity and excitoprotection in vitro. Adv Neurol 1996; 71: 1-30
16. Fabricant RN, Todaro GJ, Eldridge R. Increased levels of a nerve-growth-factor cross-reacting protein in "central" neurofibromatosis. Lancet 1979; 1: 4-7
17. Matsunaga T, Hosoda Y, Kanzaki J. Ultrastructural localization of nerve growth factor receptor in acoustic neurinoma. Acta Otolaryngol Suppl 1991;487:69-74
18. Raivich G, Zimmermann A, Sutler A. The spatial and temporal pattern of beta NGF receptor expression in the developing chick embryo. EMBO J 1985; 4: 637-644
19. Yan Q, Johnson EM jr. A quantitative study of the developmental expression of nerve growth factor (NGF) receptor in rats. Dev Biol 1987; 121: 139-148
20. Charabi S, Simonsen K, Charabi B, Jacobsen GK, Moos T, Rygaard J, Tos M, Thomsen J. Nerve growth factor receptor expression in heterotransplanted vestibular schwannoma in athymic nude mice. Acta Otolaryngol 1996; 116: 59-63
21. Yagi M, Kanzaki S, Kawamoto K, Shin B, Shah PP, Magal E, Sheng J, Raphael Y. Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. J Assoc Res Otolaryngol 2000; 1: 315-325
22. Stöver T, Gong TL, Cho Y, Altschuler RA, Lomax MI. Expression of the GDNF family members and their receptors in the mature rat cochlea. Brain Res Mol Brain Res 2000; 76: 25-35
23. Stöver T, Nam Y, Gong TL, Lomax MI, Altschuler RA. Glial cell line-derived neurotrophic factor (GDNF) and its receptor complex are expressed in the auditory nerve of the mature rat cochlea. Hear Res 2001; 155: 143-151
24. Stewart HJ, Rougon G, Dong Z, Dean C, Jessen KR, Mirsky R. TGF-betas upregulate NCAM and L1 expression in cultured Schwann cells, suppress cyclic AMP-induced expression of O4 and galactocerebroside, and are widely expressed in cells of the Schwann cell lineage in vivo. Glia 1995; 15: 419-436
25. Böttner M, Krieglstein K, Unsicker K. The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions. J Neurochem 2000; 75: 2227-2240
26. Boyd FT, Massague J. Transforming growth factor-beta inhibition of epithelial cell proliferation linked to the expression of a 53-kDa membrane receptor. J Biol Chem 1989; 264: 2272-2278
27. Laiho M, Weis MB, Massague J. Concomitant loss of transforming growth factor (TGF)-beta receptor types I and II in TGF-beta-resistant cell mutants implicates both receptor types in signal transduction. J Biol Chem 1990; 265: 18518-18524
28. Rufer M, Flanders K, Unsicker K. Presence and regulation of transforming growth factor beta mRNA and protein in the normal and lesioned rat sciatic nerve. J Neurosci Res 1994; 39: 412-423
29. Schubert D. Synergistic interactions between transforming growth factor beta and fibroblast growth factor regulate Schwann cell mitosis. J Neurobiol 1992; 23: 143-148
30. Guenard V, Gwynn LA, Wood PM. Transforming growth factor-beta blocks myelination but not ensheathment of axons by Schwann cells in vitro. J Neurosci 1995; 15: 419-428
31. Ridley AJ, Davis JB, Stroobant P, Land H. Transforming growth factors-beta 1 and beta 2 are mitogens for rat Schwann cells. J Cell Biol 1989; 109: 3419-3424
32. Cardillo MR, Filipo R, Monini S, Aliotta N, Barbara M. Transforming growth factor-beta1 expression in human acoustic neuroma. Am J Otol 1999; 20: 65-68
33. Diensthuber M, Brandis A, Lenarz T, Stöver T. Co-expression of transforming growth factor-beta1 and glial cell line-derived neurotrophic factor in vestibular schwannoma. Otol Neurotol 2004; 25: 359-365
34. Weerda HG, Gamberger TI, Siegner A, Gjuric M, Tamm ER. Effects of transforming growth factor-beta1 and basic fibroblast growth factor on proliferation of cell cultures derived from human vestibular nerve schwannoma. Acta Otolaryngol 1998; 118: 337-343
35. Bizzarri M, Filipo R, Valente MG, Bernardeschi D, Ronchetti F, Monini S, Chiappini I, Barbara M. Release of transforming growth factor beta-1 in a vestibular schwannoma cell line. Acta Otolaryngol 2002; 122: 785-787
36. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993; 260: 1130-1132
37. Golden JP, Baloh RH, Kotzbauer PT, Lampe PA, Osborne PA, Milbrandt J, Johnson EM jr. Expression of neurturin, GDNF, and their receptors in the adult mouse CNS. J Comp Neurol 1998; 398: 139-150
38. Trupp M, Ryden M, Jornvall H, Funakoshi H, Timmusk T, Arenas E, Ibanez CF. Peripheral expression and biological activities of GDNF, a new neurotrophic factor for avian and mammalian peripheral neurons. J Cell Biol 1995; 130: 137-148
39. Wefstaedt P, Scheper V, Lenarz T, Stöver T. Brain-derived neurotrophic factor/glial cell line-derived neurotrophic factor survival effects on auditory neurons are not limited by dexamethasone. Neuroreport 2005; 16: 2011-2014
40. Jing S, Wen D, Yu Y, Holst PL, Luo Y, Fang M, Tamir R, Antonio L, Hu Z, Cupples R, Louis JC, Hu S, Altrock BW, Fox GM. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 1996; 85: 1113-1124
41. Treanor JJ, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj-Bello A, Davies AM, Asai N, Takahashi M, Vandlen R, Henderson CE, Rosenthal A. Characterization of a multicomponent receptor for GDNF. Nature 1996; 382: 80-83
42. Durbec P, Marcos-Gutierrez CV, Kilkenny C, Grigoriou M, Wartiowaara K, Suvanto P, Smith D, Ponder B, Costantini F, Saarma M et al. GDNF signalling through the Ret receptor tyrosine kinase. Nature 1996; 381: 789-793
43. Iwase T, Jung CG, Bae H, Zhang M, Soliven B. Glial cell line-derived neurotrophic factor-induced signaling in Schwann cells. J Neurochem 2005; 94: 1488-1499
44. Krieglstein K, Henheik P, Farkas L, Jaszai J, Gaiter D, Krohn K, Unsicker K. Glial cell line-derived neurotrophic factor requires transforming growth factor-beta for exerting its full neurotrophic potential on peripheral and CNS neurons. J Neurosci 1998; 18: 9822-9834
45. Schober A, Hertel R, Arumae U, Farkas L, Jaszai J, Krieglstein K, Saarma M, Unsicker K. Glial cell line-derived neurotrophic factor rescues target-deprived sympathetic spinal cord neurons but requires transforming growth factor-beta as cofactor in vivo. J Neurosci 1999; 19: 2008-2015
46. Dvorak HF, Brown LF, Detmar M, Dvorak AM. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029-1039
47. Byrne AM, Bouchier-Hayes DJ, Harmey JH. Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 2005; 9: 777-794
48. Ferrara N, Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat Med 1999; 5: 1359-1364
49. Callagy G, Dimitriadis E, Harmey J, Bouchier-Hayes D, Leader M, Kay E. Immunohistochemical measurement of tumor vascular endothelial growth factor in breast cancer. A more reliable predictor of tumor stage than microvessel density or serum vascular endothelial growth factor. Appl Immunohistochem Mol Morphol 2000; 8: 104-109
50. Neufeld G, Kessler O, Vadasz Z, Gluzman-Poltorak Z. The contribution of proangiogenic factors to the progression of malignant disease: role of vascular endothelial growth factor and its receptors. Surg Oncol Clin N Am 2001; 10: 339-356
51. Eatock MM, Schatzlein A, Kaye SB. Tumour vasculature as a target for anticancer therapy. Cancer Treat Rev 2000; 26: 191-204
52. Nishikawa R, Cheng SY, Nagashima R, Huang HJ, Cavenee WK, Matsutani M. Expression of vascular endothelial growth factor in human brain tumors. Acta Neuropathol 1998; 96: 453-462
53. Charabi S. Acoustic neuroma/vestibular schwannoma in vivo and in vitro growth models. A clinical and experimental study. Acta Otolaryngol Suppl 1997; 530: 1-27
54. Labit-Bouvier C, Crebassa B, Bouvier C, Andrac-Meyer L, Magnan J, Charpin C. Clinicopathologic growth factors in vestibular schwannomas: a morphological and immunohistochemical study of 69 tumours. Acta Otolaryngol 2000; 120: 950-954
55. Taylor CM, Weiss JB, Lye RH. Raised levels of latent collagenase activating angiogenesis factor (ESAF) are present in actively growing human intracranial tumours. Br J Cancer 1991; 64: 164-168
56. Brieger J, Bedavanija A, Lehr HA, Maurer J, Mann WJ. Expression of angiogenic growth factors in acoustic neurinoma. Acta Otolaryngol 2003; 123: 1040-1045
57. Caye-Thomasen P, Werther K, Nalla A, Bog-Hansen TC, Nielsen HJ, Stangerup SE, Thomsen J. VEGF and VEGF receptor-1 concentration in vestibular schwannoma homogenates correlates to tumor growth rate. Otol Neurotol 2005; 26: 98-101
58. Cohen S. The stimulation of epidermal proliferation by a specific protein (EGF). Dev Biol 1965; 12: 394-407
59. Shiurba RA, Eng LF, Vogel H, Lee YL, Horoupian DS, Urich H. Epidermal growth factor receptor in meningiomas is expressed predominantly on endothelial cells. Cancer 1988; 62: 2139-2144
60. Sainsbury JR, Farndon JR, Needham GK, Malcolm AJ, Harris AL. Epidermal-growth-factor receptor status as predictor of early recurrence of and death from breast cancer. Lancet 1987; 1: 1398-1402
61. Quon H, Liu FF, Cummings BJ. Potential molecular prognostic markers in head and neck squamous cell carcinomas. Head Neck 2001; 23: 147-159
62. Pallini R, Tancredi A, Casalbore P, Mercanti D, Larocca LM, Consales A, Lauretti L, Fernandez E. Neurofibromatosis type 2: growth stimulation of mixed acoustic schwannoma by concurrent adjacent meningioma: possible role of growth factors. J Neurosurg 1998; 89: 149-154
63. Sturgis EM, Woll SS, Aydin F, Marrogi AJ, Amedee RG. Epidermal growth factor receptor expression by acoustic neuromas. Laryngoscope 1996; 106: 457-462
64. Itoh N, Ornitz DM. Evolution of the Fgf and Fgfr gene families. Trends Genet 2004; 20: 563-569
65. Murphy PR, Myal Y, Sato Y, Sato R, West M, Friesen HG. Elevated expression of basic fibroblast growth factor messenger ribonucleic acid in acoustic neuromas. Mol Endocrinol 1989; 3: 225-231
66. Lefebvre PP, Staecker H, Weber T, Van de Water TR, Register B, Moonen G. TGFSS1 modulates bFGF receptor message expression in cultured adult auditory neurons. Neuroreport 1991; 2: 305-308
67. Flaumenhaft R, Moscatelli D, Saksela O, Rifkin DB. Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. J Cell Physiol 1989; 140: 75-81
68. Nair SB, Leung HY, Ince P, Ramsden RT, Wilson JA. Fibroblast growth factor receptor expression in vestibular schwannoma. Clin Otolaryngol 2000; 25: 570-576
69. Garratt AN, Britsch S, Birchmeier C. Neuregulin, a factor with many functions in the life of a schwann cell. Bioessays 2000; 22: 987-996
70. Meyer D, Birchmeier C. Multiple essential functions of neuregulin in development. Nature 1995; 378: 386-390
71. Wolpowitz D, Mason TB, Dietrich P, Mendelsohn M, Talmage DA, Role LW. Cysteine-rich domain isoforms of the neuregulin-1 gene are required for maintenance of peripheral synapses. Neuron 2000; 25: 79-91
72. Taveggia C, Zanazzi G, Petrylak A, Yano H, Rosenbluth J, Einheber S, Xu X, Esper RM, Loeb JA, Shrager P, Chao MV, Falls DL, Role L, Salzer JL. Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 2005; 47: 681-694
73. Hansen MR, Linthicum FH jr. Expression of neuregulin and activation of erbB receptors in vestibular schwannomas: possible autocrine loop stimulation. Otol Neurotol 2004; 25: 155-159
74. Juul SE, Yachnis AT, Rojiani AM, Christensen RD. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr Dev Pathol 1999; 2: 148-158
75. Bartesaghi S, Marinovich M, Corsini E, Galli CL, Viviani B. Erythropoietin: a novel neuroprotective cytokine. Neurotoxicology 2005; 26: 923-928
76. Marti HH, Wenger RH, Rivas LA, Straumann U, Digicaylioglu M, Henn V, Yonekawa Y, Bauer C, Gassmann M. Erythropoietin gene expression in human, monkey and murine brain. Eur J Neurosci 1996; 8: 666-676
77. Falcioni M, Taibah A, De Donato G, Piccirillo E, Russo A, Sanna M. Fast-growing vestibular schwannoma. Skull Base Surgery 2000; 10: 95-99
78. Dillard DG, Venkatraman G, Cohen C, Delgaudio J, Gal AA, Mattox DE. Immunolocalization of erythropoietin and erythropoietin receptor in vestibular schwannoma. Acta Otolaryngol 2001; 121: 149-152